Feng Zhi

Soochow University

H指数:37

被引数:4,255

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bidirectionally H2O2-suppliable and antioxidant-consumable copper peroxide nanoparticles for photochemodynamic immunotherapy

双向H2O2可供给和抗氧化剂可消耗的铜过氧化物纳米颗粒用于光化学动力免疫疗法

Biomaterials

IF12.9

2026-01-050

PRE

Delta-opioid receptor ameliorates microglia-induced synapse loss by regulating C1q in Alzheimer disease pathology

δ-阿片受体通过调控C1q改善小胶质细胞诱导的突触丢失，以应对阿尔茨海默病病理。

Brain, Behavior, and Immunity

IF0

2025-10-230

OAAI

Polydatin ameliorates hyperhidrosis by targeting Aqp5 in a mouse model

Polydatin 通过靶向 Aqp5 改善小鼠模型中的多汗症

Frontiers in Pharmacology

IF4.8

2025-08-130

Real-time risk assessment of rice chilling injury based on disaster processes in Northeast China

基于中国东北地区灾害过程的实时水稻低温冷害风险评估

European Journal of Agronomy

IF5.5

2025-08-050

PRE

Dexmedetomidine improves septic acute kidney injury by inhibiting inflammation and oxidative stress through the activation of the Pink1/Park2 autophagy pathway

右美托咪定通过激活Pink1/Park2自噬通路，抑制炎症和氧化应激，从而改善脓毒症急性肾损伤。

Renal Failure

IF3

2025-06-080

Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity

GPX4通过靶向ZDHHC8的棕榈酰化决定了铁死亡敏感性和抗肿瘤免疫力

NATURE CANCER

IF28.5

2025-03-191

PRE

Delta-opioid receptor signaling alleviates neuropathology and cognitive impairment in the mouse model of Alzheimer's disease by regulating microglia homeostasis and inhibiting HMGB1 pathway

Δ-阿片受体信号通过调节小胶质细胞稳态和抑制HMGB1通路减轻阿尔茨海默病模型小鼠的神经病理和认知障碍

ALZHEIMERS RESEARCH & THERAPY

IF7.6

2025-02-010

OAAI

Application of cell therapy in rheumatoid Arthritis: Focusing on the immunomodulatory strategies of Mesenchymal stem cells

细胞疗法在类风湿关节炎中的应用：聚焦于间充质干细胞的免疫调节策略

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2025-02-011

PRE

Assessment of waterlogging hazard during maize growth stage in the Songliao plain based on daily scale SPEI and SMAI

AGRICULTURAL WATER MANAGEMENT

IF6.5

2024-11-010

OAAI

Targeting the TRIM14/USP14 Axis Enhances Immunotherapy Efficacy by Inducing Autophagic Degradation of PD-L1

靶向TRIM14/USP14轴通过诱导PD-L1的自噬降解增强免疫治疗功效

CANCER RESEARCH

IF16.6

2024-06-260

PRE

Index construction and real-time hazard assessment of rice sterile-type chilling injury process in Northeast China

东北地区水稻不育型冷害过程指标构建及实时危害评估

AGRICULTURAL AND FOREST METEOROLOGY

IF5.7

2024-06-011

PRE

Causal associations between circulating cytokines and risk of sepsis and related outcomes: a two-sample Mendelian randomization study

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-03-051

OAAI

A Degradation Prediction Method for PEM Fuel Cell Based on Deep Temporal Feature Extraction and Transfer Learning

IEEE TRANSACTIONS ON TRANSPORTATION ELECTRIFICATION

IF8.3

2024-03-016

PRE

Recent Advances of Tumor Microenvironment-Responsive Nanomedicines-Energized Combined Phototherapy of Cancers

肿瘤微环境响应型纳米药物赋能联合光疗肿瘤的研究进展

PHARMACEUTICS

IF5.5

2023-10-177

OAAI

Oroxylin a promoted apoptotic extracellular vesicles transfer of glycolytic kinases to remodel immune microenvironment in hepatocellular carcinoma model

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2023-10-017

PRE

NLRP6 potentiates PI3K/AKT signalling by promoting autophagic degradation of p85α to drive tumorigenesis

NATURE COMMUNICATIONS

IF15.7

2023-09-289

OAAI

Dominolike Barriers Elimination with an Intratumoral Adenosine-Triphosphate-Supersensitive Nanogel to Enhance Cancer Chemoimmunotherapy

ACS NANO

IF16

2023-09-282

PRE

Recent applications of phase-change materials in tumor therapy and theranostics

BIOMATERIALS ADVANCES

IF6

2023-04-0114

PRE

δ-opioid Receptor, Microglia and Neuroinflammation

Δ-阿片受体、小胶质细胞与神经炎症

AGING AND DISEASE

IF6.9

2023-01-017

OAAI

Dually enhanced phototherapy by gambogic acid and hyperthemia-activated chemotherapy for synergistic breast cancer treatment

CHEMICAL ENGINEERING JOURNAL

IF13.2

2023-01-0121

PRE

Feng Zhi

个人简介

教育背景

工作经历

荣誉奖项

研究方向